POST-TRIAL OPINION
McCORMICK, C.
Defendant Aurion Biotech, Inc. and one of its Series C Preferred Stockholders, Plaintiff Alcon Research, LLC, are battling over Aurion's planned IPO. Aurion wants to launch the IPO by mid-February 2025. Alcon seeks to block it. Their disagreements boil down to three issues. The first dispute concerns whether...
Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.